Skip to main content
Figure 2 | BMC Cardiovascular Disorders

Figure 2

From: Retrospective review of superficial femoral artery stenting in diabetic patients: thiazolidinedione use may decrease reinterventions

Figure 2

Freedom from SFA Stent TLR among all diabetics by TZD use. Freedom from TLR was 88.5% for diabetics taking thiazolidinediones at the time of SFA stenting vs. 61.2% for those not taking a thiazolidinedione at 2 years. This difference was statistically significant, p = 0.02, with a standard error < 10% at all points on the graph.

Back to article page